Bellevue Life Sciences-RTSBLACRPreferred / convertible
13F holders, Q4 2024 (December 31)At the end of Q4 2024, 28 institutions reported holding Bellevue Life Sciences-RTS (BLACR) in their 13F filings, unchanged from Q3 2024. 1 opened new positions and 1 sold out. The largest holders were Highbridge Capital Management LLC ($100K), Periscope Capital Inc. ($65K) and Harraden Circle Investments, LLC ($58K). 2 famous investors held it, including David E. Shaw ( of D. E. Shaw & Co.'s portfolio) and Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Bellevue Life Sciences-RTS
- CUSIP
- 079174124
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $49K |
| Exits | 1 | $2K |
All 13F filers, Q3 2024 → Q4 2024: 588,406 shares bought and 332,367 shares sold, net +256,039 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 28 holders
| Highbridge Capital Management LLC | — | No change | 836,469 | $100K |
| Periscope Capital Inc. | — | Reduce -0.6% | 485,500 | $65K |
| Harraden Circle Investments, LLC | — | — | 524,343 | $58K |
| Toronto Dominion Bank | — | New | 446,448 | $49K |
| Polar Asset Management Partners Inc. | — | No change | 360,000 | $47K |
| Boothbay Fund Management, LLC | — | No change | 311,040 | $42K |
| Atw Spac Management LLC | — | No change | 311,040 | $40K |
| JPMorgan Chase & Co. | — | No change | 300,000 | $36K |
| Saba Capital Management, L.P. | — | No change | 250,000 | $34K |
| Walleye Trading LLC | — | Add +150.0% | 236,430 | $31K |
| Rivernorth Capital Management, LLC | — | No change | 250,000 | $29K |
| Clear Street LLC | — | No change | 185,932 | $24K |
| Heights Capital Management, Inc. | — | No change | 156,176 | $20K |
| D. E. Shaw & Co. | — | No change | 150,000 | $18K |
| Shaolin Capital Management LLC | — | Reduce -52.6% | 125,000 | $16K |
| Wolverine Asset Management LLC | — | No change | 121,585 | $16K |
| AQR Arbitrage LLC | — | Reduce -1.5% | 98,528 | $13K |
| Centiva Capital, LP | — | No change | 100,000 | $12K |
| Mint Tower Capital Management B.V. | — | No change | 75,000 | $10K |
| SkyView Investment Advisors, LLC | — | No change | 30,000 | $4K |
| Gabelli Funds LLC | — | No change | 27,050 | $4K |
| Walleye Capital LLC | — | Reduce -84.4% | 26,270 | $3K |
| Citadel Advisors | — | Add +0.4% | 24,383 | $3K |
| GABELLI & Co INVESTMENT ADVISERS, INC. | — | No change | 20,800 | $3K |
| Flow Traders U.S. LLC | — | Reduce -3.7% | 15,696 | $2K |
| Schechter Investment Advisors, LLC | — | Reduce -65.9% | 15,500 | $2K |
| Wealthspring Capital LLC | — | Reduce -7.8% | 11,900 | $1K |
| Bank of America Corp. | — | No change | 100 | $11 |
"% of holder's portfolio" is BLACR's weight in each manager's 13F, not the share of Bellevue Life Sciences-RTS the manager owns.